US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
AbstractThe report covers a forecast and an analysis of the biosimulation market on a global and regional level. The study provides historical data for 2017 and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the biosimulation market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the biosimulation market on a global level. In order to give the users of this report a comprehensive view of the biosimulation market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness. The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions. The study provides a decisive view of the biosimulation market based on product, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on product, the market is segmented into services and software. The services segment is further classified into contract services and in-house services. By application, the market includes drug discovery, drug development, and others. By end-user, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations, regulatory authorities, and academic research institutions. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil. Some key players of the global biosimulation market include Dassault Systèmes SE, Certara USA, Inc., Chemical Computing Group, Physiomics, In Silico Biosciences, INOSIM Software, Advanced Chemistry Development, Inc., Schrodinger, Inc., Genedata AG, and Rhenovia Pharma Ltd., among others. This report segments the global biosimulation market as follows: Global Biosimulation Market: Product Analysis Software Services In-House Services Contract Services Global Biosimulation Market: Application Analysis Drug Development Drug Discovery Others Global Biosimulation Market: End-User Analysis Pharmaceutical and Biotechnology Companies Contract Research Organizations Regulatory Authorities Academic Research Institutions Global Biosimulation Market: Regional Analysis North America The U.S. Europe UK France Germany Asia Pacific China Japan India Latin America Brazil Middle East and Africa
Table of Contents Request Table Of Content Click To Request Sample Chapter 1. Introduction 1.1. Report description and scope 1.2. Research scope 1.3. Research methodology 1.3.1. Market research process 1.3.2. Market research methodology Chapter 2. Executive Summary 2.1. Global Biosimulation Market, 2017-2025 (USD Billion) 2.2. Global Biosimulation Market: Snapshot Chapter 3. Biosimulatio | read more...